ADI-100

N/A

Report date: 2025/04/23 11:01:27
NME

Base Information

Drug NameADI-100
Drug Alias NameADI-100
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionGlutamate decarboxylase modulatorsApoptosis stimulants
TargetsGlutamate decarboxylase
Therapy Area/IndicationsDiabetes Mellitus, Type 1EpilepsyCerebellar Ataxia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAditxt Inc
China Registration ClassN/A

Develop Information

Active CompaniesAditxt Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1EpilepsyCerebellar Ataxia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A